CN101869727A - Reinforced anti-adhesion composite gel, preparation method and application - Google Patents
Reinforced anti-adhesion composite gel, preparation method and application Download PDFInfo
- Publication number
- CN101869727A CN101869727A CN200910049933A CN200910049933A CN101869727A CN 101869727 A CN101869727 A CN 101869727A CN 200910049933 A CN200910049933 A CN 200910049933A CN 200910049933 A CN200910049933 A CN 200910049933A CN 101869727 A CN101869727 A CN 101869727A
- Authority
- CN
- China
- Prior art keywords
- adhesion
- polypeptide
- reinforced anti
- composite gel
- gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to the field of biological medicinal materials, and discloses a reinforced anti-adhesion composite gel. The reinforced anti-adhesion composite gel comprises the following components in mass/volume ratio: 0.01 to 8 percent of polysaccharide with anionic groups, 0.0000001 to 1 percent of functional polypeptide with positive charge groups, and 0.05 to 5 percent of polysaccharide with cationic groups or cationic polymerized polypeptide or mixture of the two in any ratio. The invention also provides a preparation method for the reinforced anti-adhesion composite gel. The reinforced anti-adhesion composite gel can effectively reduce the occurrence of adhesion by adding the anti-adhesion functional polypeptide with polyelectrolyte interaction and the polysaccharide with cationic groups and/or cationic polymerized polypeptide into materials.
Description
Technical field
The invention belongs to biomedical materials field, relate to a kind of being used for and have pluralgel of reinforced anti-adhesion function and its production and application behind the surgical operation.
Background technology
Adhesion behind the surgical operation between tissue and the organ is the disease that often occurs clinically, and adhesion is that connective fiber band and adjacent tissue or organ combine and the anomalous structure that forms.Adhesion forms has universality, it is reported that 50%～100% abdominal cavity and operation on pelvis can cause adhesion in various degree.The clinical severe complication that adhesion causes comprises intestinal obstruction, infertility, chronic pelvic pain etc., has increased once more the difficulty of operation and the potentiality that complication further takes place.Therefore, the reason of further investigation adhesion formation and prevention and the adhesion of minimizing surgical postoperative have become the primary study and the application direction of current surgical field.
The method of minimizing adhesion commonly used has two kinds at present: 1) directly pour into various materials, as dextran 70, heparin sodium, cortisone, antibiotic and enzyme etc., reduce or suppress fibrous connective tissue forming; 2) use interleaving agent, between wound tissue, provide mechanical barrier, as expanded polytetrafluoroethylsealing (Gore-Tex) and oxidized regenerated cellulose (Interceed TC7) surgical membrane etc.
Pay close attention to the more macromolecular material polyvinyl alcohol that has in recent years, polylactic acid etc., the biomaterial cellulose family, animal derived material such as hyaluronate sodium, the chitosan class, collagen protein, fibroin albumen, mucous membrane of animal and valve etc., they all have better biocompatibility, some albumen also remains with some active groups, help organization healing, but obvious defects is arranged also, as produce acid degradation product (poly-lactic acid material), gel and the film used are held time shorter in vivo, poor mechanical property etc., and the use of some foreign proteins brings the immunogenicity risk inevitably, in order to improve the mechanical property of these products, vivo degradation time and reduction immunogenicity, have to use cross-linking agent, cross-linking agent commonly used is glutaraldehyde (GA), GA is cross-linked material fast and effectively, reduce antigenicity, improve the stability and the mechanical property of material, but the calcification phenomenon often takes place in the material after GA handles, this is extremely harmful, and more serious cell-cytotoxic reaction usually takes place in the material part that GA handles.
Band anionic group polysaccharide carboxymethyl cellulose, carboxymethyl chitosan, hyaluronic acid are widely used in a plurality of fields as the maximum natural polysaccharide derivant of occurring in nature quantity.Carboxymethyl cellulose, carboxymethyl chitosan, hyaluronic acid all are a kind of anionic linear polymeric polysaccharose substances, outward appearance is white in color or micro-yellow powder, tasteless, nontoxic, the toughness solution that becomes soluble in water, have unique physicochemical property, and functions such as tool thickening, suspension, stable emulsifying, rheological behavior.Have good film property, high viscosity have high strength and high flexibility after carboxymethyl cellulose, carboxymethyl chitosan, the hyaluronic acid of high molecule mass are made thin film relatively, and the solution of high concentration still has good transparency.
Sodium carboxymethyl cellulose, carboxymethyl chitosan, hyaluronic acid confirm through serial toxicological experiment result: have no side effect, to skin and mucosa nonirritant, non-immunogenicity and pyrogen reaction in vivo, haemolysis not, no mutagenicity and lethal mutation effect are that the good body of histocompatibility is implanted into biomaterial.Sodium carboxymethyl cellulose, carboxymethyl chitosan, the most frequently used form of hyaluronic acid are solution, gel and film, solution or gel are applied in wound surface, but " aquation is floating " effect is played in solution uniform distribution Rhizoma Atractylodis Macrocephalae district, intercept art district and surrounding tissue, prevent that adhesion from forming.As a mechanical separator, form with glue or film covers tissue or organ wound surface, have absorbability and well reach characteristics such as biocompatibility is good, but be absorbed degraded in about in vivo about 4 days, yet damage the finishing the time more than 7 days of taking of posterior synechiae, so carboxymethyl cellulose, carboxymethyl chitosan, hyaluronic acid use the Film with Preventing Adhesion effect unsatisfactory separately.
The existing clinically in recent years product that respectively carboxymethyl cellulose, carboxymethyl chitosan, hyaluronic acid sugar is used for Film with Preventing Adhesion is solution or gel, and understanding behind the body flow with position is difficult to guarantee its concentration and time in wound site but put into.
Summary of the invention
The object of the present invention is to provide a kind of reinforced anti-adhesion composite gel, to overcome existing band anionic group polysaccharide such as carboxymethyl cellulose, carboxymethyl chitosan, hyaluronic acid and derivant thereof, pectin and derivant thereof, the deficiency of one pack system preventing adhesiving effects such as chondroitin sulfate.
The present invention also provides the preparation method of above-mentioned reinforced anti-adhesion composite gel.
Another object of the present invention is to provide the application of above-mentioned reinforced anti-adhesion composite gel.
A kind of reinforced anti-adhesion composite gel is the functional polypeptide that comprises band anionic group polysaccharide, positively charged group, the hydrogel of being with cation group polysaccharide and/or cationic polymerization polypeptide (polylysine), and wherein the mass/volume of each component ratio is:
Band anionic group polysaccharide: 0.01%～8%;
The functional polypeptide of positively charged group: 0.0000001%～1%;
Band cation group polysaccharide or cationic polymerization polypeptide, or the mixture of both arbitrary proportions: 0.05%～5%;
Described band anionic group polysaccharide is selected from sodium carboxymethyl cellulose, the derivant of carboxymethyl chitosan, hyaluronic acid, hyaluronic derivant, pectin, pectin or one or more the mixture in the chondroitin sulfate;
The functional polypeptide of described positively charged group is the functional polypeptide that one or both ends connect positively charged group, and positively charged group can be preferably one to five lysine that side chain is positively charged and/or arginine; Functional polypeptide be preferably contain-arginine-glycine-aspartic acid-polypeptide, contain-valine-glycine-Val-Pro-glycine-polypeptide or contain-isoleucine-lysine-valine-alanine-valine-polypeptide in the mixed polypeptide of one or both formation; Connect positively charged group by one or both ends, its carboxyl generation polyelectrolyte with band anionic group polysaccharide is reacted at functional polypeptide; Functional polypeptide can obtain by chemical synthesis process or gene engineering expression purification process;
Described band cation group polysaccharide is a water-soluble chitosan, and its molecular weight is 500～25000;
Described cationic polymerization polypeptide is a polylysine, and its molecular weight is 500～300000.
The functional polypeptide and the band cation group polysaccharide that in being with anionic group polysaccharide such as carboxymethyl cellulose and/or carboxymethyl chitosan, hyaluronic acid material, add positively charged group among the present invention, the positive charge group can be ingenious expediently with materials such as band anionic group polysaccharide such as carboxymethyl cellulose, carboxymethyl chitosan, hyaluronic acid in the reaction of negative charge group carboxyl generation polyelectrolyte, promptly polyelectrolyte interacts.Band anionic group polysaccharide, functional polypeptide, band cation group polysaccharide and/or cationic polymerization polypeptide form by the polyelectrolyte reaction has the complex of strengthening the anti function.
The preparation method of reinforced anti-adhesion composite gel of the present invention is: will be mixed in proportion with functional polypeptide, band cation group polysaccharide and/or cationic polymerization polypeptide and the water of anionic group polysaccharide, positively charged group, stir, to forming no cotton-shaped even gel, degerming handle reinforced anti-adhesion composite gel.
Strengthening compound anti-adhesion gel can be the aqueous gel preparation, also can be dried to gel film or sponge film, and film can be further crosslinked, helps increasing degradation time in film strength and the extension body.
The present invention is by adding an amount of interactional anti functional polypeptide of polyelectrolyte being arranged and be with cation group polysaccharide and/or cationic polymerization polypeptide in material, on the one hand, crosslinked action by the polyelectrolyte reaction, strengthen the molecular weight of material, prolong degradation time in vivo, strengthen its mechanical isolation effect; On the other hand, functional polypeptide can promote the quickening reparation recovery from illness of tissue or organ wound surface, avoids adhesion to take place, and can stop fibrin deposition, stops platelet aggregation and activation, stops albumin to ooze out, and prevents that finally adhesion from forming.Reinforced anti-adhesion composite gel of the present invention can effectively reduce the generation of adhesion phenomenon.
The specific embodiment
Embodiment 1
Take by weighing pharmaceutical grade sodium carboxymethyl cellulose 2.5 grams, add 80 milliliters of water for injection heated water bath (30～60 ℃) stirring and dissolving earlier; Add 50 milligrams of functional polypeptides, its amino acid sequence is: lysine-lysine-threonine-serine-arginine-glycine-aspartic acid-serine stirs; Add 1.5 gram chitosans (molecular weight 10000～20000), the limit edged stirs, after add injection water to 100 milliliter, stir to forming no cotton-shaped even gel, degerming handle reinforced anti-adhesion composite gel.
Embodiment 2
Take by weighing pharmaceutical grade carboxymethyl chitosan 2 grams, add 80 milliliters of water for injection heated water bath (30～60 ℃) stirring and dissolving earlier; Add 60 microgram functional polypeptides, its amino acid sequence is: lysine-lysine-cysteine-serine-arginine-glycine-aspartic acid-serine-cysteine-lysine-lysine (can be condensed into ring-type) stirs; Add 2.0 gram chitosans (molecular weight 2000～3000), the limit edged stirs, after add injection water to 100 and milliliter stir to forming no cotton-shaped even gel, degerming handle reinforced anti-adhesion composite gel.
Embodiment 3
Take by weighing pharmaceutical grade hyaluronic acid 1.5 grams, add 80 milliliters of water for injection heated water bath (30～60 ℃) stirring and dissolving earlier; Add 100 microgram functional polypeptides, its amino acid sequence is: lysine-lysine-threonine-serine-arginine-glycine-aspartic acid-serine stirs; Add 0.05 gram polylysine (molecular weight is 3000-5000), the limit edged stirs, after add injection water to 100 and milliliter stir to forming no cotton-shaped even gel, degerming handle reinforced anti-adhesion composite gel.
Embodiment 4
Take by weighing pharmaceutical grade sodium carboxymethyl cellulose 2.5 grams, add 80 milliliters of water for injection heated water bath (30～60 ℃) stirring and dissolving earlier; Add 50 microgram functional polypeptides, its amino acid sequence is: lysine-arginine-threonine-serine-arginine-glycine-aspartic acid-serine-lysine-lysine stirs; Add 1.0 gram chitosans (molecular weight 6000～8000) and 0.5 gram polylysine (molecular weight is 1000-5000), the limit edged stirs, after add injection water to 100 and milliliter stir to the no cotton-shaped even gel of formation, degerming handle reinforced anti-adhesion composite gel.
Embodiment 5
Take by weighing pharmaceutical grade sodium hydroxyethlcellulose 6 grams, add 80 milliliters of water for injection heated water bath (30～60 ℃) stirring and dissolving earlier; Add 5 milligrams of functional polypeptides, its amino acid sequence is: lysine-arginine-threonine-serine-arginine-glycine-aspartic acid-serine-lysine-lysine stirs; Add 1.0 gram chitosans (molecular weight 6000～8000) and 0.3 gram polylysine (molecular weight is 10000-30000), the limit edged stirs, after add injection water to 100 and milliliter stir to forming no cotton-shaped even gel, degerming handle reinforced anti-adhesion composite gel.
Embodiment 6
Take by weighing aching and limp ossein 0.2 gram of pharmaceutical grade bright sulfur, add 80 milliliters of water for injection heated water bath stirring and dissolving earlier; Add 1 milligram of functional polypeptide, its amino acid sequence is: lysine-lysine-threonine-serine-arginine-glycine-aspartic acid-serine stirs; Add 0.5 gram polylysine (molecular weight is 150000-300000), the limit edged stirs, after add injection water to 100 and milliliter stir to forming no cotton-shaped even gel, degerming handle reinforced anti-adhesion composite gel.
Embodiment 7
Take by weighing pharmaceutical grade sodium carboxymethyl cellulose 1.5 grams and pectin 2 grams, add 80 milliliters of water for injection heated water bath (30～60 ℃) stirring and dissolving earlier; Add 100 microgram functional polypeptides, its amino acid sequence is: lysine-arginine-threonine-serine-arginine-glycine-aspartic acid-serine-lysine-lysine stirs; Add 0.05 gram polylysine (molecular weight is 1000-5000), the limit edged stirs, after add injection water to 100 and milliliter stir to forming no cotton-shaped even gel, degerming handle reinforced anti-adhesion composite gel.
Embodiment 8 strengthens the comparison of compound anti-adhesion gel and existing single component anti-adhesion gel preventing adhesiving effect:
36 of Wister rats, body weight (220 ± 40) gram, male and female are regardless of, and are divided into 3 groups at random: the A group is matched group, and B group and C group respectively are 12 for experimental group, and all animals adopts etherization, anaesthetizes safe back dorsal position, is fixed on the operating-table.Take off median abdominal incision, be about 4 centimetres, successively go into abdomen, propose caecum, be interrupted with knife blade in 20 centimetres at the ileum end and peel off ileum serous coat band, wide 0.3 centimetre, be about 4 centimetres, totally 3 places.Form face at A then and do not do other processing, close abdomen.B form face inject the sodium carboxymethyl cellulose gel (concentration 2.5%, 3.5ml); C forms the reinforced anti-adhesion composite gel 3.5ml that face injects embodiment 1.
The postoperative sub-cage rearing, the equal fasting of postoperative 10 hours, feedstuff is rat pellet of the same race.10 days all animals of postoperative are put to death.With reference to adhesion grade staging: 0 grade of no adhesion, the ileum serosal surface is repaired fully; The only loose a small amount of adhesion of I level, easily separated, no oozing of blood, big reparation of ileum serous coat; The adhesion of II level is slightly close than the I level, oozing of blood during separation, and the ileum serous coat is repaired about half; The adhesion of III level become bulk or with the extensive adhesion of other internal organs, do not block but have, ileum serous coat small part is repaired; The adhesion of IV level is extensive, and densification has intestinal obstruction, and the near-end dilatation of intestine is obvious.The intra-abdominal adhesions situation is evaluated classification.
The result shows: each organizes the adhesion significant difference, the A group is the III---IV level, the B group is based on the I level, the C group is based on the 0---I level, B group adhesion grade obviously alleviates than the A group, two groups of differences have significance meaning (P＜0.01), and C group adhesion grade obviously alleviates than the B group, and two groups of differences have significance meaning (P＜0.01).
Embodiment 9 strengthens the comparison of compound anti-adhesion gel film and existing single component anti-adhesion gel preventing adhesiving effect
Get the reinforced anti-adhesion composite gel 4ml of embodiment 1, place 3 centimetres culture dish sialorrhea film forming, the lyophilization anti-adhesion gel sponge film that strengthened in 24 hours carries out the adhesion grade relatively with said method.
A group is matched group, and B group and C group are experimental group, B form face inject the sodium carboxymethyl cellulose gel (concentration 2.5%, 3.5ml); C forms face and uses above-mentioned reinforced anti-adhesion gel sponge film.The result shows, each organizes the adhesion significant difference, the A group is the III---IV level, the B group is based on the I level, the C group is based on the 0---I level, and B group adhesion grade obviously alleviates than the A group, and two groups of differences have significance meaning (P＜0.01), C group adhesion grade obviously alleviates than the B group, and two groups of differences have significance meaning (P＜0.01).
Claims (8)
1. a reinforced anti-adhesion composite gel is characterized in that, is the functional polypeptide that comprises band anionic group polysaccharide, positively charged group, the hydrogel of being with cation group polysaccharide and/or cationic polymerization polypeptide, and wherein the mass/volume of each component ratio is:
Band anionic group polysaccharide: 0.01%～8%;
The functional polypeptide of positively charged group: 0.0000001%～1%;
Band cation group polysaccharide or cationic polymerization polypeptide, or the mixture of both arbitrary proportions: 0.05%～5%;
Described band anionic group polysaccharide is selected from one or more the mixture in sodium carboxymethyl cellulose and derivant, carboxymethyl chitosan and derivant, hyaluronic acid and derivant, pectin and derivant or the chondroitin sulfate;
The functional polypeptide of described positively charged group is that one or both ends connect one to five lysine that side chain is positively charged and/or arginic functional polypeptide.
2. the described a kind of reinforced anti-adhesion composite gel of claim 1, it is characterized in that, described functional polypeptide be contain-arginine-glycine-aspartic acid-polypeptide, contain-valine-glycine-Val-Pro-glycine-polypeptide or contain-isoleucine-lysine-valine-alanine-valine-polypeptide in the mixed polypeptide of one or both formation.
3. the described a kind of reinforced anti-adhesion composite gel of claim 1 is characterized in that, described band cation group polysaccharide is a water-soluble chitosan.
4. the described a kind of reinforced anti-adhesion composite gel of claim 3 is characterized in that, described water-soluble chitosan molecular weight is 500～250000.
5. the described a kind of reinforced anti-adhesion composite gel of claim 1 is characterized in that, described cationic polymerization polypeptide is a polylysine.
6. the described a kind of reinforced anti-adhesion composite gel of claim 5 is characterized in that, described polylysine molecular weight is 500～300000.
7. the preparation method of the described reinforced anti-adhesion composite gel of claim 1, it is characterized in that, the preparation method of reinforced anti-adhesion composite gel of the present invention is: will be mixed in proportion with functional polypeptide, band cation group polysaccharide and/or cationic polymerization polypeptide and the water of anionic group polysaccharide, positively charged group, stir, to forming no cotton-shaped even gel, degerming handle reinforced anti-adhesion composite gel.
8. the application of described 1 reinforced anti-adhesion composite gel of claim aspect preparation reinforced anti-adhesion gel film or reinforced anti-adhesion sponge film.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200910049933 CN101869727B (en) | 2009-04-24 | 2009-04-24 | Reinforced anti-adhesion composite gel, preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200910049933 CN101869727B (en) | 2009-04-24 | 2009-04-24 | Reinforced anti-adhesion composite gel, preparation method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101869727A true CN101869727A (en) | 2010-10-27 |
| CN101869727B CN101869727B (en) | 2013-05-29 |
Family
ID=42994929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200910049933 Active CN101869727B (en) | 2009-04-24 | 2009-04-24 | Reinforced anti-adhesion composite gel, preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101869727B (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102614551A (en) * | 2012-03-31 | 2012-08-01 | 山西伯朗生物技术有限公司 | Preparation method for medical absorbable anti-adhesion film |
| CN102772821A (en) * | 2012-08-01 | 2012-11-14 | 苏州博创同康生物工程有限公司 | Absorbable and hemostatic multifunctional particle with tissue induction and preparation and application of multifunctional particle |
| CN103189078A (en) * | 2010-10-29 | 2013-07-03 | 汇美迪斯有限公司 | Adhesion barrier containing hyaluronic acids and L-arginine |
| CN105392468A (en) * | 2013-05-20 | 2016-03-09 | 高敏 | Preparation method of mussel adhesive protein gel, mussel adhesive protein gel and use thereof |
| CN105879127A (en) * | 2016-04-25 | 2016-08-24 | 东莞市联洲知识产权运营管理有限公司 | Method for preparing postoperative adhesion prevention materials |
| CN106038517A (en) * | 2016-03-14 | 2016-10-26 | 苏州博创康源生物技术有限公司 | Polysaccharide medicine loading tissue adhesion film and preparing method thereof |
| CN106038516A (en) * | 2016-03-14 | 2016-10-26 | 苏州博创康源生物技术有限公司 | Compound drug loading tissue pasting membrane and preparation method thereof |
| CN106220873A (en) * | 2016-08-16 | 2016-12-14 | 潘忠宁 | A kind of synthetic method of microgel base composite aquogel |
| CN107823701A (en) * | 2017-10-27 | 2018-03-23 | 温州生物材料与工程研究所 | A kind of poly glycosyl styptic sponge, preparation technology and application with active hemostatic function |
| CN113243548A (en) * | 2021-05-18 | 2021-08-13 | 河南卷烟工业烟草薄片有限公司 | Preparation method of low-viscosity low-irritation reconstituted tobacco of heated cigarette |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040005350A1 (en) * | 2002-06-28 | 2004-01-08 | Looney Dwayne Lee | Hemostatic wound dressings and methods of making same |
| CN1685829A (en) * | 2005-04-30 | 2005-10-26 | 武汉大学 | Preparation method of chitin/zinc compound bactericide |
| CN101036780A (en) * | 2007-04-27 | 2007-09-19 | 四川大学 | Application of self-assembled short peptide in the medicine for treating burn and face wound |
| WO2007142579A1 (en) * | 2006-06-05 | 2007-12-13 | Bactiguard Ab | A polymer matrix, uses thereof and a method of manufacturing the same |
-
2009
- 2009-04-24 CN CN 200910049933 patent/CN101869727B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040005350A1 (en) * | 2002-06-28 | 2004-01-08 | Looney Dwayne Lee | Hemostatic wound dressings and methods of making same |
| CN1685829A (en) * | 2005-04-30 | 2005-10-26 | 武汉大学 | Preparation method of chitin/zinc compound bactericide |
| WO2007142579A1 (en) * | 2006-06-05 | 2007-12-13 | Bactiguard Ab | A polymer matrix, uses thereof and a method of manufacturing the same |
| CN101036780A (en) * | 2007-04-27 | 2007-09-19 | 四川大学 | Application of self-assembled short peptide in the medicine for treating burn and face wound |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103189078A (en) * | 2010-10-29 | 2013-07-03 | 汇美迪斯有限公司 | Adhesion barrier containing hyaluronic acids and L-arginine |
| CN102614551A (en) * | 2012-03-31 | 2012-08-01 | 山西伯朗生物技术有限公司 | Preparation method for medical absorbable anti-adhesion film |
| CN102772821A (en) * | 2012-08-01 | 2012-11-14 | 苏州博创同康生物工程有限公司 | Absorbable and hemostatic multifunctional particle with tissue induction and preparation and application of multifunctional particle |
| CN105392468A (en) * | 2013-05-20 | 2016-03-09 | 高敏 | Preparation method of mussel adhesive protein gel, mussel adhesive protein gel and use thereof |
| CN106038517A (en) * | 2016-03-14 | 2016-10-26 | 苏州博创康源生物技术有限公司 | Polysaccharide medicine loading tissue adhesion film and preparing method thereof |
| CN106038516A (en) * | 2016-03-14 | 2016-10-26 | 苏州博创康源生物技术有限公司 | Compound drug loading tissue pasting membrane and preparation method thereof |
| CN105879127A (en) * | 2016-04-25 | 2016-08-24 | 东莞市联洲知识产权运营管理有限公司 | Method for preparing postoperative adhesion prevention materials |
| CN106220873A (en) * | 2016-08-16 | 2016-12-14 | 潘忠宁 | A kind of synthetic method of microgel base composite aquogel |
| CN107823701A (en) * | 2017-10-27 | 2018-03-23 | 温州生物材料与工程研究所 | A kind of poly glycosyl styptic sponge, preparation technology and application with active hemostatic function |
| CN113243548A (en) * | 2021-05-18 | 2021-08-13 | 河南卷烟工业烟草薄片有限公司 | Preparation method of low-viscosity low-irritation reconstituted tobacco of heated cigarette |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101869727B (en) | 2013-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101869727B (en) | Reinforced anti-adhesion composite gel, preparation method and application | |
| US20220008612A1 (en) | Preparation and/or formulation of proteins cross-linked with polysaccharides | |
| Kumar et al. | Application of xanthan gum as polysaccharide in tissue engineering: A review | |
| Wu et al. | Chitosan-based composite hydrogels for biomedical applications | |
| US8691793B2 (en) | Modified macromolecules and associated methods of synthesis and use | |
| US5510418A (en) | Glycosaminoglycan-synthetic polymer conjugates | |
| Park et al. | RGD-conjugated chitosan-pluronic hydrogels as a cell supported scaffold for articular cartilage regeneration | |
| WO2009006780A1 (en) | A method for the formation of a rapid-gelling biocompatible hydrogel and the preparation of a spraying agent | |
| CN101849850B (en) | Bionic in-situ regeneration repair nano sticking patch and preparation method and application thereof | |
| US20100190704A1 (en) | Structure comprising chitosan and collagen | |
| Milivojevic et al. | Biological macromolecules in cell encapsulation | |
| CN115429935B (en) | Injectable cross-linked chondroitin sulfate hydrogel and preparation method thereof | |
| Li et al. | Review on adaptation between biomaterials function of chitosan and its structure | |
| Collins et al. | Hydrogel functionalization and crosslinking strategies for biomedical applications | |
| Bombaldi de Souza et al. | Xanthan Gum for Regenerative Medicine | |
| Joseph et al. | Cross-Linking Biopolymers for Biomedical Applications | |
| Mallik et al. | Biodegradability and biocompatibility of natural polymers | |
| KR101074467B1 (en) | An antiadhesion barrier comprising hyaluronic acid and Ｌ-Arginine | |
| Kaur et al. | Polymers as Bioactive Materials-I: Natural and Non-degradable Polymers | |
| EP4368213A1 (en) | Tissue formation agent | |
| Tombuloglu et al. | Materials for articular cartilage regeneration | |
| Bhilare et al. | Biodegradability and Biodegradable Polymers: An Overview | |
| Duru et al. | Principle Renewable Biopolymers and Their Biomedical Applications | |
| Rauh et al. | 20 Complex Polysaccharides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: WU CHANGLIN Free format text: FORMER OWNER: SUZHOU BOCHUANG TONGKANG BIOENGINEERING CO., LTD. Effective date: 20110719 Owner name: LIU GUANGWAN |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 215300 NO. 1333, SHUIXIU ROAD, YUSHAN TOWN, KUNSHAN CITY, JIANGSU PROVINCE TO: 200062 ROOM 101, NO. 55, LANE 895, JINSHAJIANG ROAD, SHANGHAI |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20110719 Address after: 101 room 55, 895 lane, Jinsha River Road, Shanghai, 200062 Applicant after: Wu Changlin Co-applicant after: Liu Guangwan Address before: 215300 Jiangsu Province, Yushan town of Kunshan City Shueisiou Road No. 1333 Applicant before: Suzhou Bochuang Tongkang Biological Engineering Co., Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190513 Address after: 215300 4th Floor, Pilot Building 168 Yuanfeng Road, Yushan Town, Kunshan City, Jiangsu Province Patentee after: Suzhou Bochuang Tongkang Biological Engineering Co., Ltd. Address before: Room 101, No. 55, 895 Lane, Jinshajiang Road, Shanghai 200062 Co-patentee before: Liu Guangwan Patentee before: Wu Changlin |